Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans.
about
Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery DiseaseTrimethylamine N-oxide: breathe new life.Gut Microbiota and Atherosclerosis.Gut-Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet.Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial.Relationship between serum trimethylamine N-oxide and exposure to dioxin-like pollutants.Metabolic, Epigenetic, and Transgenerational Effects of Gut Bacterial Choline Consumption.Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota.Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.Microbial modulation of cardiovascular disease.Associations of current diet with plasma and urine TMAO in the KarMeN study: direct and indirect contributions.Gut Microbiota and Cardiovascular Uremic ToxicitiesGlucose and Fat Tolerance Tests Induce Differential Responses in Plasma Choline Metabolites in Healthy SubjectsImplication of gut microbiota metabolites in cardiovascular and metabolic diseasesThe Association between Plasma Levels of Trimethylamine N-Oxide and the Risk of Coronary Heart Disease in Chinese Patients with or without Type 2 Diabetes Mellitus
P2860
Q36340545-5F717FDF-01FC-406E-ADF1-DF43E8FB46B3Q37434802-198541CA-506B-49CD-959C-1E062F547720Q39459129-31785479-6ACF-4F0A-A33E-645AF98C456DQ40079055-4A0256CC-928A-4772-9D04-1013EDD4F898Q47162918-7ED9BEA2-9379-4B9E-A6C6-2240229E54F7Q47172271-3424870F-6BFF-4EE7-B646-C6743335DCD0Q47651164-9DEC7724-077C-423D-A596-6299492A0C0EQ47749634-945B9600-0212-447D-8052-EB5A2EB9C146Q48014347-2BA2E57C-5E4D-4D69-9838-EF89A043AF72Q48048891-C64BCC3D-B96F-4B26-9490-E0E112CE2F47Q49501260-F5F67269-BE08-4464-95AD-9F4E2094411DQ50144047-44139A6B-08B7-4EC8-B9FD-8FC5C053C56EQ50201612-5F483E40-7198-43BC-B73C-1B8FD2A39652Q57176511-D5C2850A-D2D3-488D-98CD-905ABF071372Q58773211-379D7FB7-BD8E-4B4A-9EDE-0B285B04C814Q58787534-D06D0188-EA1B-42D6-913E-A728C6CA4B06Q58795227-49F20349-2F0C-4CC5-8459-E218F4A51516
P2860
Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Relationship of Serum Trimethy ...... rly Atherosclerosis in Humans.
@en
type
label
Relationship of Serum Trimethy ...... rly Atherosclerosis in Humans.
@en
prefLabel
Relationship of Serum Trimethy ...... rly Atherosclerosis in Humans.
@en
P2093
P2860
P356
P1433
P1476
Relationship of Serum Trimethy ...... rly Atherosclerosis in Humans.
@en
P2093
Alfred Königsrainer
Andreas Fritsche
Andreas Peter
Angela Lehn-Stefan
Bernd Balletshofer
Elko Randrianarisoa
Fritz Schick
Guowang Xu
Ingmar Königsrainer
Jürgen Machann
P2860
P2888
P356
10.1038/SREP26745
P407
P577
2016-05-27T00:00:00Z